These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 16508189)
41. Metronidazole/Hydroxypropyl-β-Cyclodextrin inclusion complex nanofibrous webs as fast-dissolving oral drug delivery system. Celebioglu A; Uyar T Int J Pharm; 2019 Dec; 572():118828. PubMed ID: 31715341 [TBL] [Abstract][Full Text] [Related]
42. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics. Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389 [TBL] [Abstract][Full Text] [Related]
43. Characterization and in vivo evaluation of an inclusion complex of oridonin and 2-hydroxypropyl-beta-cyclodextrin. Yan Z; Xu W; Sun J; Liu X; Zhao Y; Sun Y; Zhang T; He Z Drug Dev Ind Pharm; 2008 Jun; 34(6):632-41. PubMed ID: 18568914 [TBL] [Abstract][Full Text] [Related]
44. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. Patel SG; Rajput SJ AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053 [TBL] [Abstract][Full Text] [Related]
45. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat. Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689 [TBL] [Abstract][Full Text] [Related]
46. Improvement of Pharmaceutical Properties of Zerumbone, a Multifunctional Compound, Using Cyclodextrin Derivatives. Hassan MM; Mohammed AFA; Elamin KM; Devkota HP; Ohno Y; Motoyama K; Higashi T; Imai T Chem Pharm Bull (Tokyo); 2020; 68(11):1117-1120. PubMed ID: 33132380 [TBL] [Abstract][Full Text] [Related]
47. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin. Liu J; Qiu L; Gao J; Jin Y Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034 [TBL] [Abstract][Full Text] [Related]
48. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state. Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969 [TBL] [Abstract][Full Text] [Related]
49. Influence of hydroxypropyl beta-cyclodextrin on the stability of benzylpenicillin in chloroacetate buffer. Ong JK; Sunderland VB; McDonald C J Pharm Pharmacol; 1997 Jun; 49(6):617-21. PubMed ID: 9330202 [TBL] [Abstract][Full Text] [Related]
50. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related]
51. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. Lopez RF; Collett JH; Bentley MV Int J Pharm; 2000 Apr; 200(1):127-32. PubMed ID: 10845694 [TBL] [Abstract][Full Text] [Related]
53. Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben. Tanaka M; Iwata Y; Kouzuki Y; Taniguchi K; Matsuda H; Arima H; Tsuchiya S J Pharm Pharmacol; 1995 Nov; 47(11):897-900. PubMed ID: 8708982 [TBL] [Abstract][Full Text] [Related]
54. Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex. Chen X; Sun X; Ren K; Zhang X; Zhang Z; Gong T Arzneimittelforschung; 2010; 60(9):571-4. PubMed ID: 21117501 [TBL] [Abstract][Full Text] [Related]
55. Hydroxypropyl-β-cyclodextrin functionalized calcium carbonate microparticles as a potential carrier for enhancing oral delivery of water-insoluble drugs. Zhang L; Zhu W; Lin Q; Han J; Jiang L; Zhang Y Int J Nanomedicine; 2015; 10():3291-302. PubMed ID: 25995635 [TBL] [Abstract][Full Text] [Related]
56. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling. Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001 [TBL] [Abstract][Full Text] [Related]
57. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities. Yoshida A; Yamamoto M; Irie T; Hirayama F; Uekama K Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1059-63. PubMed ID: 2766408 [TBL] [Abstract][Full Text] [Related]
58. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation. Pathak SM; Musmade P; Dengle S; Karthik A; Bhat K; Udupa N Eur J Pharm Sci; 2010 Nov; 41(3-4):440-51. PubMed ID: 20656025 [TBL] [Abstract][Full Text] [Related]
59. Controlled release of a water-soluble drug, captopril, by a combination of hydrophilic and hydrophobic cyclodextrin derivatives. Ikeda Y; Kimura K; Hirayama F; Arima H; Uekama K J Control Release; 2000 May; 66(2-3):271-80. PubMed ID: 10742586 [TBL] [Abstract][Full Text] [Related]
60. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC. Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]